• Subscribe
  • Magazine
  • Past Issues
  • Surveys
  • Industry Statistics
  • About Us
  • Members Only
  • Best Places to Work
    • Recent Quotes
    My Watchlist
    Indicators
    PennEnergy Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    MoonLake Immunotherapeutics - Class A Ordinary Shares (NQ: MLTX )

    43.97 +2.28 (+5.47%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Jun 28, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 671,959
    Open 42.13
    Bid (Size) 39.51 (1)
    Ask (Size) 45.88 (1)
    Prev. Close 41.69
    Today's Range 41.12 - 44.58
    52wk Range 35.11 - 64.98
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    MoonLake Immunotherapeutics Announces Positive Regulatory Feedback from both FDA and EMA on Path for the Phase 3 Program for the Nanobody® sonelokimab in Psoriatic Arthritis
    From MoonLake Immunotherapeutics AG
    Via GlobeNewswire
    MoonLake Immunotherapeutics starts Phase 3 VELA program of the Nanobody® sonelokimab in patients with moderate-to-severe hidradenitis suppurativa
    From MoonLake Immunotherapeutics AG
    Via GlobeNewswire

    Performance

    YTD
    -26.16%
    -26.16%
    1 Month
    +7.04%
    +7.04%
    3 Month
    -9.53%
    -9.53%
    6 Month
    -27.19%
    -27.19%
    1 Year
    -13.92%
    -13.92%

    More News

    Read More
    MLTX Stock Earnings: MoonLake Misses EPS for Q1 2024
    Via InvestorPlace
    MoonLake Immunotherapeutics Inks Three-Year Technology Partnership With Komodo Health To Advance Research on Inflammatory Skin and Joint Conditions
    From Komodo Health
    Via Business Wire
    Expert Ratings for MoonLake
    Via Benzinga
    Recap: MoonLake Q3 Earnings
    Via Benzinga
    Why Diodes Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session
    Via Benzinga
    MoonLake Jumps After Arthritis Drug Tops AbbVie Blockbuster Humira In A Key Test
    Via Investor's Business Daily
    16 Analysts Have This to Say About MoonLake
    Via Benzinga
    Why Is Inflammatory Disease-Focused MoonLake Immunotherapeutics Stock Trading Higher Today?
    Via Benzinga
    MoonLake announces significant improvements with Nanobody® sonelokimab over 24 weeks in active psoriatic arthritis (PsA) and other important updates at its R&D Day
    From MoonLake Immunotherapeutics AG
    Via GlobeNewswire
    MoonLake Immunotherapeutics to present MIRA trial data of Nanobody® sonelokimab in hidradenitis suppurativa as a late breaker at the AAD Annual Meeting 2024
    From MoonLake Immunotherapeutics AG
    Via GlobeNewswire
    Cooper Companies Reports Upbeat Results, Joins Dell, NetApp, Tidewater And Other Big Stocks Moving Higher On Friday
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    MoonLake Immunotherapeutics Announces Positive Feedback from both FDA and EMA on Regulatory Path for the Phase 3 Program of the Nanobody® sonelokimab (SLK) in Hidradenitis Suppurativa (HS)
    From MoonLake Immunotherapeutics AG
    Via GlobeNewswire
    12 Health Care Stocks Moving In Wednesday's After-Market Session
    Via Benzinga
    Why Former Highflier MoonLake Plummeted 29% After A Recent Run
    Via Investor's Business Daily
    Dow Turns Lower; EchoStar Shares Plunge
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Why Bluegreen Vacations Shares Are Trading Higher By Around 105%? Here Are Other Stocks Moving In Monday's Mid-Day Session
    Via Benzinga
    12 Health Care Stocks Moving In Monday's Intraday Session
    Via Benzinga
    Crude Oil Moves Higher; BioNTech Lowers 2023 Sales Outlook
    Via Benzinga
    Topics Stocks
    Exposures Fossil Fuels US Equities
    Why Is Arthritis-Focused MoonLake Immunotherapeutics Stock Trading Lower Today?
    Via Benzinga
    TreeHouse Foods, EchoStar, Hilton Grand Vacations, EchoStar And Other Big Stocks Moving Lower On Monday
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    US Stocks Rise; Nasdaq Gains 50 Points
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    12 Health Care Stocks Moving In Monday's Pre-Market Session
    Via Benzinga
    MoonLake Immunotherapeutics announces landmark Phase 2 results for Nanobody® sonelokimab in active psoriatic arthritis
    From MoonLake Immunotherapeutics AG
    Via GlobeNewswire
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.